pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,487
stories
2d
CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline
fiercebiotech
2d
Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds
biopharma dive
2d
MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’
fiercebiotech
2d
ArriVent collapses on disappointing lung cancer data
biopharma dive
2d
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
biopharma dive
2d
ArriVent's lung cancer drug firmonertinib fails key late-stage trial, stock tanks
endpoints
2d
STAT+: AstraZeneca opens new Boston site
stat
2d
STAT+: Are stem cell treatments about to have their day?
stat
2d
AbbVie, Genmab's Epkinly sets ‘new standard of care’ in first-line lymphoma in Phase 3
biospace
2d
The top biopharma conferences in 2027
biopharma dive
2d
ArriVent’s phase 3 lung cancer trial flops, sinking stock
fiercebiotech
2d
GE HealthCare to acquire Sofie Biosciences for $945M
biopharma dive
2d
Kairos seizes moment to push prostate cancer prospect into earlier setting
fiercebiotech
2d
Opinion: Why the FDA should not approve an ineffective multicancer screening test
stat
3d
AstraZeneca hopes to ‘achieve amazing things’ with new Kendall Square R&D center
fiercebiotech
3d
TRex Bio stomps toward $111M IPO, as Retension and Lycia also gear up to go public
fiercebiotech
3d
Biotech’s peptide shows promise as ‘bait molecule’ to treat neuropathic pain in mice
fiercebiotech
3d
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
stat
3d
2 Massachusetts biotechs call it quits
biospace
3d
Genmab details ovarian cancer data; Lilly's Jaypirca gets a label expansion
endpoints
3d
Special report 2026: Meet 20 women changing the biopharma industry as we know it
endpoints
3d
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
biopharma dive
3d
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
stat
3d
STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
stat
3d
Could we one day vaccinate against every cancer?
stat
3d
How AI is transforming biopharma manufacturing facilities of the future
biopharma dive
3d
Precision for All: Closing the gap between innovation and impact
biopharma dive
3d
Hospital and pharmaceutical prices are smothering America’s businesses
stat
3d
STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions
stat
3d
Opinion: Will Claude ever win a Nobel Prize for medicine?
stat
← prev
page 2 of 50
next →
